- Home
- DRCT vs XAIR Comparison
DRCT vs XAIR Comparison
Compare DRCT & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRCT | XAIR |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 10.1M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DRCT | XAIR |
|---|---|---|
| Price | $1.00 | $0.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $330.00 | $11.00 |
| AVG Volume (30 Days) | ★ 270.9K | 254.1K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.09 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $62,288,000.00 | $3,705,000.00 |
| Revenue This Year | N/A | $126.42 |
| Revenue Next Year | $58.17 | $130.48 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 219.67 |
| 52 Week Low | $0.04 | $0.15 |
| 52 Week High | $6.04 | $3.78 |
Technical Indicators
Market Signals| Indicator | DRCT | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 33.58 |
| Support Level | $0.40 | $0.67 |
| Resistance Level | $1.96 | $1.25 |
| Average True Range (ATR) | 0.17 | 0.09 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 28.00 | 9.34 |
Price Performance
Historical ComparisonAbout DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.